- Home
- CUE vs DSWL Comparison
CUE vs DSWL Comparison
Compare CUE & DSWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | DSWL |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | United States | Macau |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.6M | 56.7M |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CUE | DSWL |
|---|---|---|
| Price | $0.49 | $3.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 390.5K | 15.5K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 6.02% |
| EPS Growth | N/A | ★ 20.23 |
| EPS | N/A | ★ 0.78 |
| Revenue | $7,100,000.00 | ★ $65,664,000.00 |
| Revenue This Year | $36.58 | N/A |
| Revenue Next Year | $32.10 | N/A |
| P/E Ratio | ★ N/A | $4.30 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.47 | $1.93 |
| 52 Week High | $1.75 | $4.48 |
Technical Indicators
Market Signals| Indicator | CUE | DSWL |
|---|---|---|
| Relative Strength Index (RSI) | 30.51 | 36.42 |
| Support Level | $0.47 | $3.53 |
| Resistance Level | $0.51 | $3.64 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 9.40 | 0.00 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About DSWL Deswell Industries Inc.
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.